Comparison of different promoter methylation assays in breast cancer

Analytical Cellular Pathology

Volumn 33, Issue 3-4, 2010, Pages 133-141

  Suijkerbuijk, Karijn P M ^a   Pan, Xiaojuan ^a   Van Der Wall, Elsken ^a   Van Diest, Paul J ^a   Vooijs, Marc ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Breast cancer; DNA methylation; methodology; MS MLPA; MSP; QM MSP

Indexed keywords

DNA;

ARTICLE; ASSAY; BREAST CANCER; CCND2 GENE; DNA METHYLATION; GENE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; METHYLATION ASSAY; METHYLATION SPECIFIC MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; METHYLATION SPECIFIC POLYMERASE CHAIN REACTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE MULTIPLEX METHYLATION SPECIFIC POLYMERASE CHAIN REACTION; RARB GENE; RASSF1 GENE; SCGB3A1 GENE; BIOASSAY; BREAST TUMOR; FEMALE; GENETICS; IN VITRO STUDY; METHODOLOGY; PROMOTER REGION;

BIOLOGICAL ASSAY; BREAST NEOPLASMS; DNA METHYLATION; FEMALE; HUMANS; PROMOTER REGIONS, GENETIC;

EID: 79952553019     PISSN: 22107177     EISSN: 22107185     Source Type: Journal    
DOI: 10.3233/ACP-CLO-2010-0542     Document Type: Article

References (26)

1. E. Capel, J.F. Flejou and R. Hamelin, Assessment of MLH1 promoter methylation in relation to gene expression requires specific analysis, Oncogene 26 (2007), 7596-7600. (Pubitemid 350207716)
2. J. Coffa, M.A. van de Wiel, B. Diosdado, B. Carvalho, J. Schouten and G.A. Meijer, MLPAnalyzer: data analysis tool for reliable automated normalization of MLPA fragment data, Cell. Oncol. 30 (2008), 323-335. (Pubitemid 352032908)
3. M.J. Fackler, K. Malone, Z. Zhang, E. Schilling, E. Garrett-Mayer, T. Swift-Scanlan et al., Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid, Clin. Cancer Res. 12 (2006), 3306-3310.
4. M.J. Fackler, M. McVeigh, J. Mehrotra, M.A. Blum, J. Lange, A. Lapides et al., Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer, Cancer Res. 64 (2004), 4442-4452. (Pubitemid 38856915)
5. E.H. Gort, K.P.M. Suijkerbuijk, S.M. Roothaan, V. Raman, M. Vooijs, E. van der Wall et al., Methylation of the TWIST1 promoter, TWIST1 mRNA levels, and immunohistochemical expression of TWIST1 in breast cancer, Cancer Epidemiol. Biomarkers Prev. 17 (2008), 3325-3330.
6. J.G. Herman, J.R. Graff, S. Myohanen, B.D. Nelkin and S.B. Baylin, Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands, PNAS 93 (1996), 9821-9826. (Pubitemid 26296693)
7. M.O. Hoque, Q. Feng, P. Toure, A. Dem, C.W. Critchlow, S.E. Hawes et al., Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer, J. Clin. Oncol. 24 (2006), 4262-4269. (Pubitemid 46630783)
8. G.J. Jenkins, G.L. Williams, J. Beynon, Z. Ye, J.N. Baxter and J.M. Parry, Restriction enzymes in the analysis of genetic alterations responsible for cancer progression, Br. J. Surg. 89 (2002), 8-20. (Pubitemid 34031302)
9. J.W.M. Jeuken, S.J.B. Cornelissen, M. Vriezen, M.M.G. Dekkers, A. Errami, A. Sijben et al., MS-MLPA: an attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomas, Lab. Invest. 87 (2007), 1055-1065. (Pubitemid 47429190)
10. P.A. Jones and S.B. Baylin, The fundamental role of epigenetic events in cancer, Nat. Rev. Genet. 3 (2002), 415-428. (Pubitemid 34587077)
11. R. Krassenstein, E. Sauter, E. Dulaimi, C. Battagli, H. Ehya, A. Klein-Szanto et al., Detection of breast cancer in nipple aspirate fluid by CpG island hypermethylation, Clin. Cancer Res. 10 (2004), 28-32. (Pubitemid 38114158)
12. L.S. Kristensen and L.L. Hansen, PCR-based methods for detecting single-locus DNA methylation biomarkers in cancer diagnostics, prognostics, and response to treatment, Clin. Chem. 55 (2009), 1471-1483.
13. P.W. Laird, The power and the promise of DNA methylation markers, Nat. Rev. Cancer 3 (2003), 253-266. (Pubitemid 37328861)
14. C.M. Lewis, L.R. Cler, D.W. Bu, S. Zochbauer-Muller, S. Milchgrub, E.Z. Naftalis et al., Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk, Clin. Cancer Res. 11 (2005), 166-172. (Pubitemid 40081117)
15. Z.J. Liu and M. Maekawa, Polymerase chain reaction-based methods of DNA methylation analysis, Anal. Biochem. 317 (2003), 259-265. (Pubitemid 36581887)
16. C.B. Moelans, R.A. de Weger, M.T.M. van Blokland, C. Ezendam, S. Elshof, M.G.J. Tilanus et al., HER-2/neu amplification testing in breast cancer by multiplex ligation-dependent probe amplification in comparison with immunohistochemistry and in situ hybridization, Cell. Oncol. 31(1) (2009), 1-10.
17. A.O.H. Nygren, N. Ameziane, H.M.B. Duarte, R.N.C.P. Vijzelaar, Q. Waisfisz, C.J. Hess et al., Methylation-Specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences, Nucl. Acids Res. 33 (2005), e128.
18. L. Pasquali, A. Bedeir, S. Ringquist, A. Styche, R. Bhargava and G. Trucco, Quantification of CpG island methylation in progressive breast lesions from normal to invasive carcinoma, Cancer Lett. 257 (2007), 136-144. (Pubitemid 47464705)
19. G. Sharma, S. Mirza, Y.H. Yang, R. Parshad, P. Hazrah, S. Datta Gupta et al., Prognostic relevance of promoter hypermethylation of multiple genes in breast cancer patients, Cell. Oncol. 31 (2009), 487-500.
20. K.P. Suijkerbuijk, M.J. Fackler, S. Sukumar, C.H. van Gils, T. van Laar, E. van derWall et al., Methylation is less abundant in BRCA1-associated compared with sporadic breast cancer, Ann. Oncol. 19 (2008), 1870-1874.
21. K.P.M. Suijkerbuijk, P.J. van Diest and E. van der Wall, Improving early breast cancer detection: focus on methylation, Ann. Oncol. (2010); doi: 10.1093/annonc/mdg305. [Epub June 29 2010.]
22. K.P.M. Suijkerbuijk, E. van der Wall and P.J. van Diest, Oxytocin: bringing magic into nipple aspiration, Ann. Oncol. 18, 2007, 1743-1744. (Pubitemid 47506264)
23. T. Swift-Scanlan, A. Blackford, P. Argani, S. Sukumar and M.J. Fackler, Two-color quantitative multiplex methylationspecific PCR, Biotechniques 40 (2006), 210-219. (Pubitemid 46542642)
24. P.J. van Diest, No consent should be needed for using leftover body material for scientific purposes, BMJ 325 (2002), 648-651.
25. M. Weller, R. Stupp, G. Reifenberger, A.A. Brandes, M.J. van den Bent,W.Wick et al., MGMT promoter methylation in malignant gliomas: ready for personalized medicine?, Nat. Rev. Neurol. 6 (2010), 39-51.
26. P.S. Yan, C. Venkataramu, A. Ibrahim, J.C. Liu, R.Z. Shen and N.M. Diaz et al., Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue, Clin. Cancer Res. 12 (2006), 6626-6636. (Pubitemid 44876830)